Faraday Richard M MD is categorized under Infectious Disease Specialists in Orange, CA and active since 2001.
Faraday Richard M MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Richard Faraday at the company’s single location by writing to 705 West La Veta Avenue # 114, Orange, California CA 92868 or by phoning (714) 997-5597. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Faraday Richard M MD |
| Contact Person: | Richard Faraday |
| Address: | 705 West La Veta Avenue # 114, Orange, California 92868 |
| Phone Number: | (714) 997-5597 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Faraday Richard M MD was started in 2001 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Richard Faraday for inquiries that concern Faraday Richard M MD by calling the company number (714) 997-5597, as your correspondence is most welcome. Additionally, the physical location of the single location of Faraday Richard M MD can be found at the coordinates 33.78066,-117.8603 as well as the street address 705 West La Veta Avenue # 114 in Orange, California 92868.
For its online presence, you may visit Faraday Richard M MD’s website at and engage with its social media outlets through on Twitter and on Facebook.